However, patients with CD in remission fare much better than those with persistence of hypercortisolism, and they appear not to have an increased mortality rate.

然而，随着库欣病患者缓解，预后明显要比持续高皮质醇血症患者要好，他们似乎死亡率没有增加。

youdao

However, patients with CD in remission fare much better than those with persistence of hypercortisolism, and they appear not to have an increased mortality rate.

然而，随着库欣病患者缓解，预后明显要比持续高皮质醇血症患者要好，他们似乎死亡率没有增加。

youdao